News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
TB services
CDC report on U.S. TB drug shortage reflects local and global challenges

According to an article in this week’s Morbidity and Mortality Weekly Report, the 26 health departments handling about 75 percent of the United States tuberculosis caseload have confronted multidrug-resistant tuberculosis, with 21 of those departments — more than 80 percent – facing obstacles to getting the medicine necessary to treat it.

Published
21 January 2013
From
Science Speaks
Finance and funding
Reaction to BBC reporting on generic ARVs

Yesterday the BBC issued a misleading news report on the efficacy of generic antiretroviral drugs (ARVs) suggesting that generic ARVs are less efficacious than branded alternatives. The report, based upon a study led by Massachusetts General Hospital (MGH) and Weill Cornell Medical College investigators, fails to separate the issues of ‘treatment efficacy’ and ‘adherence’ leading to distorted and alarmist conclusions.

Published
17 January 2013
From
Stop AIDS Campaign
Pharmaceutical industry
Médecins Sans Frontières addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV

The just-released study stating that switching patients from the branded combination antiretroviral ‘Atripla’ to generics could be therapeutically ‘less effective’ is misleading and misses a big part of the picture. The harmful role played by patents in blocking the use of quality-assured generic combination drugs is overlooked. The article further conflates evidence that single-pill "fixed-dose combination" HIV drugs lead to better treatment outcomes with the false notion that generic medicines themselves may lead to worse outcomes.

Published
17 January 2013
From
MSF / EATG
Access to medicines and treatment
ZIMBABWE: Still struggling with drug shortages

Chronic shortages of generic and antiretroviral drugs, stock-outs, high medication costs, and long distances to clinics are some of the hurdles people face in their quest to access essential medicines in Zimbabwe.

Published
11 January 2013
From
IRIN Plus News
Drug-resistant TB
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis

Several new classes of anti-tuberculosis agents are likely to become available in the coming decade. Ensuring prompt access to these drugs for patients without other treatment options is an important medical and public health issue. This article reviews the current state of ‘compassionate use’ and ‘expanded access’ programs for these new drugs, and identifies several shortcomings that will limit patient access to the drugs.

Published
11 January 2013
From
Interrnational Journal of Tuberculosis and Lung Disease
Access to medicines and treatment
Uganda still behind on ARV target

Uganda continues to fall short of achieving its goal of ensuring that 80 percent of people living with HIV receive antiretroviral drugs (ARVs) by 2015, according to the Uganda AIDS Commission (UAC).

Published
08 January 2013
From
IRIN Plus News
Access to medicines and treatment
Indonesia: HIV treatment available only in high-prevalence areas

“Access to antiretroviral treatment is improving, but coverage remains focused on areas with high HIV infection rates such as East Java, Jakarta, Papua and West Java,” an AIDS activist told The Jakarta Post.

Published
04 January 2013
From
Jakarta Post
Access to medicines and treatment
Thai-EU Free Trade Agreement Raises Alarm for People With AIDS

Days before leaders of the European Union (EU) arrived in Norway to collect this year’s Nobel Peace prize, Thai public health activists sent a letter to the northern powerhouse, warning that the EU’s 2012 accolades face a credibility test in this Southeast Asian country.

Published
03 January 2013
From
Inter Press Service
Diagnosing children
Point-of-care (POC) diagnostics are essential to achieving an AIDS-free generation and improving outcomes in HIV-exposed children

This edition reviews recent evidence on point-of-care testing, on tests in development, and looks at experience of optimising performance of dried blood spot sampling.

Published
14 December 2012
From
HIV & AIDS treatment in practice
Pharmaceutical industry
US: AIDS physician groups tell pharma to lower prices

Two organizations that represent more than 5,000 physicians and other healthcare providers who are dedicated to HIV and AIDS care have written several drugmakers to various steps to expand access to their medicines, such as lowering prices, expanding co-pays, ensuring formulary coverage and participating in the Harbor Path program that provides patient assistance.

Published
12 December 2012
From
Pharmalot
← Prev1...34567...46Next →

Filter by country